Q2 2024 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2024-08-14 · accession 0000902664-24-005144
$39.8M
Reported value
7
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $17.6M | 44.2% | 1,017,751 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $9.4M | 23.6% | 276,831 | Common | SHARED |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $7.1M | 17.9% | 667,778 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $2.7M | 6.85% | 65,933 | Common | SHARED |
| 90042W100 | — | TURNSTONE BIOLOGICS CORP | $1.4M | 3.62% | 549,980 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $777,470 | 1.95% | 474,067 | Common | SHARED |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $730,588 | 1.84% | 352,941 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.